GB1492361A - Optically active m-acyloxy-alpha(methylamino)methyl)-benzyl alcohols the pharmaceutically acceptable acid addition salts thereof and synthesis of same - Google Patents

Optically active m-acyloxy-alpha(methylamino)methyl)-benzyl alcohols the pharmaceutically acceptable acid addition salts thereof and synthesis of same

Info

Publication number
GB1492361A
GB1492361A GB5020/76A GB502076A GB1492361A GB 1492361 A GB1492361 A GB 1492361A GB 5020/76 A GB5020/76 A GB 5020/76A GB 502076 A GB502076 A GB 502076A GB 1492361 A GB1492361 A GB 1492361A
Authority
GB
United Kingdom
Prior art keywords
optically active
methyl
acyloxy
acid addition
addition salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5020/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interx Research Corp
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/548,606 external-priority patent/US3966749A/en
Application filed by Interx Research Corp filed Critical Interx Research Corp
Publication of GB1492361A publication Critical patent/GB1492361A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB5020/76A 1975-02-10 1976-02-09 Optically active m-acyloxy-alpha(methylamino)methyl)-benzyl alcohols the pharmaceutically acceptable acid addition salts thereof and synthesis of same Expired GB1492361A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/548,606 US3966749A (en) 1975-02-10 1975-02-10 Novel synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols, the pharmaceutically acceptable acid addition salts thereof and intermediate useful in the preparation thereof
US57807975A 1975-05-16 1975-05-16

Publications (1)

Publication Number Publication Date
GB1492361A true GB1492361A (en) 1977-11-16

Family

ID=27068909

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5020/76A Expired GB1492361A (en) 1975-02-10 1976-02-09 Optically active m-acyloxy-alpha(methylamino)methyl)-benzyl alcohols the pharmaceutically acceptable acid addition salts thereof and synthesis of same

Country Status (5)

Country Link
JP (1) JPS51125339A (enrdf_load_stackoverflow)
AU (1) AU1097976A (enrdf_load_stackoverflow)
DE (1) DE2605111A1 (enrdf_load_stackoverflow)
FR (2) FR2299860A1 (enrdf_load_stackoverflow)
GB (1) GB1492361A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2933005C2 (de) * 1979-08-14 1983-01-13 Klinge Pharma GmbH, 8000 München 1-(3-Acyloxyphenyl)-2-aminoethanole, deren Säureadditionssalze, diese enthaltende Arzneimittel, sowie Verfahren zu ihrer Herstellung
JPS5960914U (ja) * 1982-10-19 1984-04-21 株式会社パイロット ランドセル

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2341876A1 (de) * 1973-08-18 1975-03-13 Boehringer Sohn Ingelheim Neue 1-(m-acyloxyphenyl)-1-hydroxy- 2-n-alkylamino-aethane, deren saeureadditionssalze, diese enthaltende arzneimittel, sowie verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPS56420B2 (enrdf_load_stackoverflow) 1981-01-08
JPS51125339A (en) 1976-11-01
FR2319634B1 (enrdf_load_stackoverflow) 1979-03-23
AU1097976A (en) 1977-08-18
DE2605111A1 (de) 1976-08-19
FR2299860B1 (enrdf_load_stackoverflow) 1979-10-05
FR2319634A1 (fr) 1977-02-25
FR2299860A1 (fr) 1976-09-03

Similar Documents

Publication Publication Date Title
GB1505305A (en) Benzcycloamide derivatives
FI891176A0 (fi) Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
HK85984A (en) Nasal pharmaceutical compositions
AU539976B2 (en) Therapeutically active compounds
JPS5671073A (en) Imidazole derivative
IE812273L (en) Cephalosporin derivatives
GB1492361A (en) Optically active m-acyloxy-alpha(methylamino)methyl)-benzyl alcohols the pharmaceutically acceptable acid addition salts thereof and synthesis of same
IE42763L (en) Tertiary amino alkylphenyl ether compounds, anesthetics
GB1448026A (en) 2-aminomethyleneindanone analgesic agents
IL66789A (en) 6-amino-benzocyclo-pentane,-hexane,and-heptane derivatives,processes for their preparation and pharmaceutical preparations containing them
EP0281412A3 (en) Novel organic platinum complex pharmaceutical compositions containing same and a process for the preparation thereof
GB1400319A (en) Pharmaceutical compositions
GB1511006A (en) Pyrazolopyridines
AU2692988A (en) Derivatives of thioformamide
MY104540A (en) Pharmaceutical preparations.
GB1418595A (en) N- 2-alkoxybenzoyl- amino acids and a process for producing the same
GB1322069A (en) Aminoalkanoylaminocyclohexane derivatives
FI860098A0 (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
GB1254270A (en) Benzoxazepine derivatives
GB1527483A (en) 2-aminomethyl-5-phenyloxazoles and the pharmaceutically acceptable acid addition salts thereof
GB1393979A (en) Piperidine derivatives
GB1425729A (en) 1,4-dihydropyridine compounds
GB1231613A (enrdf_load_stackoverflow)
GB1509409A (en) Pharmaceutically active thiozolidine derivatives
GB1496625A (en) Nicotinyl carnitine derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee